3) CARES Act - SARS COV-2 VSV vaccine

Abstract

Initiate non-clinical development to determine efficacy of a SARS CoV-2 Vesicular Stomatitis (VSV) vaccine.

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2022
Source ID
586acc17045524efb6781262fe8828fe

Tags

Technology Areas

  • Biotechnology

Related Documents